Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Rothwell

Showing results (31-40 of 477) with videos related to

Pageof 48
Sort By:
Lancet (London, England)|July 28, 2004
Lessons from MATCH for future randomised trials in secondary prevention of strokePeter M Rothwell
The Lancet. Neurology|August 20, 2005
Lack of epidemiological data on secondary stroke preventionPeter M Rothwell
Annals of Internal Medicine|July 17, 2013
Alternate-day, low-dose aspirin and cancer riskPeter M Rothwell
The Lancet. Neurology|December 17, 2016
Stroke research in 2016: when more medicine is better, and when it isn'tPeter M Rothwell
Cerebrovascular Diseases (Basel, Switzerland)|May 13, 2003
Incidence, risk factors and prognosis of stroke and TIA: the need for high-quality, large-scale epidemiological studies and meta-analysesPeter M Rothwell
Lancet (London, England)|January 11, 2005
External validity of randomised controlled trials: "to whom do the results of this trial apply?"Peter M Rothwell
Neurologic Clinics|November 26, 2008
Endarterectomy for symptomatic and asymptomatic carotid stenosisPeter M Rothwell
Nature Clinical Practice. Cardiovascular Medicine|January 21, 2009
Is intravenous recombinant plasminogen activator effective up to 4.5 h after onset of ischemic stroke?Peter M Rothwell
Lancet (London, England)|March 16, 2010
Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertensionPeter M Rothwell
International Journal of Stroke : Official Journal of the International Stroke Society|August 19, 2008
Lack of research funding for strokePeter M Rothwell
Pageof 48

Showing results (31-40 of 477) with videos related to

Sort By:
Pageof 48
Lancet (London, England)|July 28, 2004
Lessons from MATCH for future randomised trials in secondary prevention of strokePeter M Rothwell
The Lancet. Neurology|August 20, 2005
Lack of epidemiological data on secondary stroke preventionPeter M Rothwell
Annals of Internal Medicine|July 17, 2013
Alternate-day, low-dose aspirin and cancer riskPeter M Rothwell
The Lancet. Neurology|December 17, 2016
Stroke research in 2016: when more medicine is better, and when it isn'tPeter M Rothwell
Cerebrovascular Diseases (Basel, Switzerland)|May 13, 2003
Incidence, risk factors and prognosis of stroke and TIA: the need for high-quality, large-scale epidemiological studies and meta-analysesPeter M Rothwell
Lancet (London, England)|January 11, 2005
External validity of randomised controlled trials: "to whom do the results of this trial apply?"Peter M Rothwell
Neurologic Clinics|November 26, 2008
Endarterectomy for symptomatic and asymptomatic carotid stenosisPeter M Rothwell
Nature Clinical Practice. Cardiovascular Medicine|January 21, 2009
Is intravenous recombinant plasminogen activator effective up to 4.5 h after onset of ischemic stroke?Peter M Rothwell
Lancet (London, England)|March 16, 2010
Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertensionPeter M Rothwell
International Journal of Stroke : Official Journal of the International Stroke Society|August 19, 2008
Lack of research funding for strokePeter M Rothwell
Pageof 48